Tumor heterogeneity is deeply associated with regional perfusion. Improved evaluation of local perfusion, by imaging or histology, can be useful for tracking tumor progression and treatment. Here we use h13C-tert-butanol, a high-SNR quantitative MRI perfusion marker, to map perfusion in untreated (UT) and sunitinib-resistant (SR) renal cell carcinoma (RCC) xenografts. This study investigates the correlation between these perfusion maps with histologic measures of vascularity using CD31-labeled sections.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords